August 24, 2016 4:48 AM ET

Pharmaceuticals

Company Overview of Sumitomo Dainippon Pharma Co., Ltd.

Executive Profile

Hiroshi Nomura

Executive Vice President and Director, Sumitomo Dainippon Pharma Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
----

Background

Mr. Hiroshi Nomura serves as Executive Vice President of Sumitomo Dainippon Pharma Co Ltd since April 1, 2016 and served as its Senior Executive Officer from 2014 to April 1, 2016. Mr. Nomura serves as the Chairman of the Board and Chief Executive Officer of Sunovion Respiratory Development Inc. He served as a Vice Chairman, Chief Financial Officer and Executive Vice President of Sunovion Pharmaceuticals Inc. He served as the President of Boston Biomedical Pharma Inc. ...

Corporate Headquarters

6-8 Doshomachi 2-chome
Osaka, -- 541-0045

Japan

Phone: 81 6 6203 5321
Fax: 81 6 6202 6028

Board Members Memberships

Chairman and Chief Executive Officer
2012-Present
Executive Vice President and Director

Education

Bachelor's Degree
Tokyo University of Science

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey J. Clarke Chief Executive Officer and Director
Eastman Kodak Co.
$1.0M
Shigetaka Komori Chairman, Group Chief Executive Officer and Executive Officer
FUJIFILM Holdings Corporation
$207.0M
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
$230.0M
Dayanand Thandalam Sriram Managing Director, Director, Member of Nomination & Remuneration Committee, Member of Risk Management & Corporate Governance Monitoring Committee, Member of Finance Committee and Member of Administrative Committee
GlaxoSmithKline Consumer Nigeria Plc
--
John Anthony Sedor Chairman, Chief Executive Officer and Member of Nominating Committee
Pernix Therapeutics Holdings, Inc.
--
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sumitomo Dainippon Pharma Co., Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.